Cutaneous manifestation of COVID‐19 reporting from Middle‐Eastern countries: A point of view!

Abdelmaksoud, Ayman; Shakshouk, Hadir; Goldust, Mohamad; Dursun, Recep; Temiz, Selami Aykut; Vestita, Michelangelo

doi:10.1111/ijd.15258

Cited by 3 publications

(3 citation statements)

References 14 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While awaiting these data, it is crucial for all health professionals to be knowledgeable of the wide varieties of dermatological manifestations in patients with COVID-19. 18 In a country like Afghanistan, where people ignore or cannot afford to pay for preventive measures and have little knowledge about the third wave of this highly contagious infection, this report is important from a public health point of view. 19 The infection among young adults may contribute to community transmission of the disease, including to persons at higher risk of getting severe illness.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Third Wave of the COVID-19 Arrived in Afghanistan: A Severe Case with Skin Manifestation

Sediqi¹,

Nemat²,

Raufi³

et al. 2021

IMCRJ

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…While awaiting these data, it is crucial for all health professionals to be knowledgeable of the wide varieties of dermatological manifestations in patients with COVID-19. 18 …”

Section: Discussionmentioning

confidence: 99%

The Third Wave of the COVID-19 Arrived in Afghanistan: A Severe Case with Skin Manifestation

Sediqi¹,

Nemat²,

Raufi³

et al. 2021

IMCRJ

View full text Add to dashboard Cite

“…The pathophysiology and significance of these signs remain uncertain, despite relatively common. Viral hypersensitivity reactions, over‐expression of type I interferon, COVID‐19 induced coagulopathy, thrombotic microangiopathy, and direct viral endothelial damage are among the proposed theories 33 34 speculated that itching, even if mild, in COVID‐19 patients might be a marker for the severity of the disease, for example, lung involvement.…”

Section: Cutaneous Reactionsmentioning

confidence: 99%

Cutaneous and Allergic reactions due to COVID‐19 vaccinations: A review

Temiz

Abdelmaksoud

Wollina

et al. 2021

J of Cosmetic Dermatology

Self Cite

View full text Add to dashboard Cite

Introduction The pandemic caused by the novel coronavirus disease 2019 (COVID‐19) has had an unprecedented impact on the overall health and the global economy. Vaccination is currently the most dependable strategy to end the pandemic, despite the slower‐than‐hoped‐for rollout, particularly for low‐to‐middle‐income countries, and the uncertain duration of protection afforded by vaccination. The spike protein of the virus (immunodominant antigen of the virus) is the main target of the approved and candidate SARS‐CoV‐2 vaccines. This protein binds to the ACE2 receptor of the host cell, initiating the entry of the virus into the cell and the chain of subsequent events ending to Acute Respiratory Distress Syndrome. The safety profile of these vaccines needs is closely assessed. Methods This comprehensive review includes searching the PubMed, EMBASE, and Web of Science databases using the keywords “coronavirus”, “COVID‐19”, “vaccine”, “cutaneous reactions”, “allergic reactions”, and “SARS‐CoV‐2”. Manual searching of reference lists of included articles augmented the research. The research was updated in June 2021. Results In this narrative review, we tried to investigate and discuss the cutaneous and allergic reactions related to SARS‐CoV‐2 vaccines currently available in the literature. As a result, although COVID‐19 vaccines can be reported to develop allergic and anaphylactic reactions, especially after m‐RNA vaccines, they remain at a low rate, and it is observed that these reactions may develop more frequently, especially in patients with previous allergies and mast cell disorders. Fortunately, these reactions are generally transient, benign, self‐limited. Conclusion Although there is still no definitive evidence, as dermatologists, we must be aware of the possibility of cutaneous reactions, newly diagnosed dermatoses, or exacerbation of existing dermatoses that may develop after the COVID‐19 vaccinations.

show abstract